2-chloro-n(6)cyclopentyladenosine has been researched along with morphine in 4 studies
Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
---|---|---|---|---|---|
252 | 0 | 43 | 44,270 | 5,200 | 8,695 |
Protein | Taxonomy | 2-chloro-n(6)cyclopentyladenosine (IC50) | morphine (IC50) |
---|---|---|---|
Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amin, EA; Dosa, PI | 1 |
Gross, GJ; Peart, JN | 1 |
Berrino, L; Capuano, A; De Novellis, V; Filippelli, A; Mazzeo, F; Rossi, F; Stella, L; Vitelli, MR | 1 |
Forconi, S; Gori, T; Liuni, A; Luca, MC; Münzel, T; Muxel, S; Parker, JD | 1 |
2 review(s) available for 2-chloro-n(6)cyclopentyladenosine and morphine
Article | Year |
---|---|
Tactical Approaches to Interconverting GPCR Agonists and Antagonists.
Topics: Animals; Humans; Ligands; Models, Molecular; Molecular Structure; Receptors, G-Protein-Coupled; Structure-Activity Relationship | 2016 |
Chronic pharmacological preconditioning against ischemia.
Topics: Adenosine; Animals; Cardiotonic Agents; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Preconditioning, Myocardial; Mice; Morphine; Myocardial Infarction; Nitric Oxide Synthase Type II; Nitroglycerin; Rats; Swine | 2011 |
2 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and morphine
Article | Year |
---|---|
Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors.
Topics: Adenosine; Analgesics, Opioid; Animals; ATP-Binding Cassette Transporters; Benzylidene Compounds; Free Radicals; Heart Diseases; In Vitro Techniques; KATP Channels; Mitochondria, Heart; Morphine; Myocardial Infarction; Myocardial Reperfusion Injury; Naltrexone; Potassium Channels; Potassium Channels, Inwardly Rectifying; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor Cross-Talk; Receptors, Opioid, delta; Receptors, Purinergic P1 | 2003 |
Interactive role of adenosine and dopamine in the opiate withdrawal syndrome.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Chromatography, High Pressure Liquid; Dopamine; Injections, Subcutaneous; Male; Microdialysis; Morphine; Pyrimidines; Rats; Rats, Wistar; Receptors, Dopamine; Substance Withdrawal Syndrome; Triazoles | 2003 |